CB
Creative BioTherapeutics LLC
SEC filingBiotechnology · Gurnee, IL
Amount raised$947Ksold at filing
Total offering$10M$9.1M still open
Investors in the raise22count reported to the SEC
FiledJul 29, 2025first sale Aug 15, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Donald Kay DavidsonExecutive Officer
Anita Kay DavidsonExecutive Officer
Executive officers, directors and promoters as listed on the Form D.